CN1055853C - Chinese drug for osteoporosis and the preparation thereof - Google Patents

Chinese drug for osteoporosis and the preparation thereof Download PDF

Info

Publication number
CN1055853C
CN1055853C CN96115053A CN96115053A CN1055853C CN 1055853 C CN1055853 C CN 1055853C CN 96115053 A CN96115053 A CN 96115053A CN 96115053 A CN96115053 A CN 96115053A CN 1055853 C CN1055853 C CN 1055853C
Authority
CN
China
Prior art keywords
portions
chinese patent
vitamin
patent medicine
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN96115053A
Other languages
Chinese (zh)
Other versions
CN1155430A (en
Inventor
芦传有
刘国森
金炫
阎文生
孙美蓉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Local State-Owned Harbin Pharmaceutic Factory No6
Original Assignee
Local State-Owned Harbin Pharmaceutic Factory No6
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Local State-Owned Harbin Pharmaceutic Factory No6 filed Critical Local State-Owned Harbin Pharmaceutic Factory No6
Priority to CN96115053A priority Critical patent/CN1055853C/en
Publication of CN1155430A publication Critical patent/CN1155430A/en
Application granted granted Critical
Publication of CN1055853C publication Critical patent/CN1055853C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention belongs to a new medicine which combines traditional Chinese medicines and Western medicines, particularly relates to a Chinese patent medicine for treating osteoporosis and a preparation method thereof. The Chinese patent medicine is characterized in that the Chinese patent medicine is prepared from 27 to 35 portions of animal bone, 9 to 11 portions of tortoise shell, 8 to 9 portions of prepared rhizome of rehmannia, 8 to 9 portions of phellodendron bark, 8 to 9 portions of barbary wolfberry fruit, 7 to 8 portions of cochinchnese asparagus root, 0.5 to 1 portion of vitamin k, 0.2 to 0.5 portion of vitamin D, 20 to 30 portions of auxiliary materials (powdered sugar, powdered milk, magnesium stearate), wherein the animal bone comprises 9 to 13 portions of ox bone, 9 to 11 portions of horse's bone and 9 to 11 portions of pig's bone. The Chinese patent medicine has outstanding therapeutic effect on renal deficiency type osteoporosis, the total effective rate of treatment is 90.72%, and the total effective rate of treating vitamin deficiency type rickets reaches 93.5%.

Description

A kind of treatment osteoporosis Chinese patent medicine
The invention belongs to the new drug that Chinese medicine and Western medicine are synthesized together, be specially a kind of treatment osteoporosis Chinese patent medicine and preparation method.
Osteoporosis is a kind of frequently-occurring, metabolic osteopathy, is one of difficult problem of the honest research tackling key problem of present medical circle.The at present clinical medicine of replenishing the calcium is mostly because of after absorbing bad or absorbing, and calcium phosphorus can not deposit in skeleton.The medicine calcium source of generally replenishing the calcium is to adopt inorganic or organic calcium salt, adopts marine organisms skeleton (shell) to handle and get in addition.Only solved the calcareous problem that partially absorbs.
The object of the present invention is to provide a kind of treatment and prevention of osteoporosis to reach good absorbing, deposition is fast, the new drug of the effect of calcium-tonifying bone-strengthening.
The object of the present invention is achieved like this: animal bone 27-35 part, Carapax Et Plastrum Testudinis 9-11 part, Radix Rehmanniae Preparata 8-9 part, Cortex Phellodendri 8-9 part, Fructus Lycii 8-9 part, Radix Asparagi 7-8 part, vitamin K class 0.5-1 part, vitamin D class 0.2-0.5 part, adjuvant (Icing Sugar, milk powder, magnesium stearate) 20-30 part are formed, and method for making is: a, get animal bone component number add water decoct repeatedly, cataclasm, dry, to be crushed to fine powder standby; B, get Chinese crude drug component number and decoct with water twice, merged decoction liquor in each 4-6 hour, be concentrated into extractum, drying under reduced pressure is ground into fine powder; C, get a, b fine powder and add the adjuvant mix homogeneously, moistening with 50-75% ethanol, make suitable soft material, granulation, drying, granulate, tabletting.Animal bone is Os Bovis seu Bubali 9-13 part, Os Equi 9-11 part, Os Sus domestica 9-11 part.
The invention has the advantages that renal deficiency type osteoporosis determined curative effect.Treatment group total effective rate 90.72%, to the rickets of vitamin deficiency, the treatment total effective rate is 93.5%, and safety non-toxic, has no side effect.
Embodiments of the invention: animal bone 27-35 part, Carapax Et Plastrum Testudinis 9-11 part, Radix Rehmanniae Preparata 8-9 part, Cortex Phellodendri 8-9 part, Fructus Lycii 8-9 part, Radix Asparagi 7-8 part, vitamin K class 0.5-1 part, vitamin D class 0.2-0.5 part, adjuvant (Icing Sugar, milk powder, magnesium stearate) 20-30 part are formed. method for making is a, get animal bone component number add water decoct repeatedly, cataclasm, dry, to be crushed to fine powder standby; B, get Chinese crude drug component number and decoct with water twice, each 4-6 hour, merge decoction liquor, be concentrated into extractum, drying under reduced pressure is ground into fine powder; C, get a, b fine powder and add the adjuvant mix homogeneously, moistening with 50-75% ethanol, make suitable soft material, granulation, drying, granulate, tabletting.Animal bone is Os Bovis seu Bubali 9-13 part, Os Equi 9-11 part, Os Sus domestica 9-11 part.The present invention is nontoxic through Heilungkiang institute of traditional Chinese medicine, the Heilungkiang academy of traditional Chinese medicine, Harbin City institute of traditional Chinese medicine three tame hospital clinical trials, have no side effect.Treatment renal deficiency type osteoporosis total effective rate is 90.72%, and obvious effective rate is 37.11%; Treatment vitamin D deficiency total effective rate 93.5%, obvious effective rate 32.6%.

Claims (2)

1. treat the osteoporosis Chinese patent medicine for one kind, it is characterized in that each composition divides by weight, animal bone 27-35 part, Carapax Et Plastrum Testudinis 9-11 part, Radix Rehmanniae Preparata 8-9 part, Cortex Phellodendri 8-9 part, Fructus Lycii 8-9 part, Radix Asparagi 7-8 part, vitamin K class 0.5-1 part, vitamin D class 0.2-0.5 part, adjuvant 20-30 part are made, and method for making is: a get animal bone component number add water decoct repeatedly, cataclasm, dry, to be crushed to powder standby; B gets Chinese crude drug component number and decocts with water twice, and each 4-6 hour, merge decoction liquor, be concentrated into extractum, drying under reduced pressure is ground into fine powder; C gets a, the b fine powder adds the adjuvant mix homogeneously, and is moistening with 50-75% ethanol, makes suitable soft material, granulation, drying, granulate, tabletting.
2. a kind of treatment osteoporosis Chinese patent medicine according to claim 1 is characterized in that: animal bone is Os Bovis seu Bubali 9-13 part, Os Equi 9-11 part, Os Sus domestica 9-11 part.
CN96115053A 1996-01-25 1996-01-25 Chinese drug for osteoporosis and the preparation thereof Expired - Fee Related CN1055853C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96115053A CN1055853C (en) 1996-01-25 1996-01-25 Chinese drug for osteoporosis and the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96115053A CN1055853C (en) 1996-01-25 1996-01-25 Chinese drug for osteoporosis and the preparation thereof

Publications (2)

Publication Number Publication Date
CN1155430A CN1155430A (en) 1997-07-30
CN1055853C true CN1055853C (en) 2000-08-30

Family

ID=5122354

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96115053A Expired - Fee Related CN1055853C (en) 1996-01-25 1996-01-25 Chinese drug for osteoporosis and the preparation thereof

Country Status (1)

Country Link
CN (1) CN1055853C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009007774A1 (en) * 2006-07-07 2009-01-15 Avestha Gengraine Technologies Pvt. Ltd. Asparagus racemosa extracts for treating osteoporosis and the extraction process thereof
CN104729236A (en) * 2015-03-05 2015-06-24 济南康众医药科技开发有限公司 Method for drying animal medicine
CN106266489A (en) * 2015-05-13 2017-01-04 蒋蓉 One treats osteoporosis Chinese patent medicine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1089115A (en) * 1992-09-30 1994-07-13 津国肇 Method for preserving of crude marine alga and preserved food thereof
CN1096953A (en) * 1993-07-02 1995-01-04 周勇 A kind of Chinese medicine for the treatment of osteoporosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1089115A (en) * 1992-09-30 1994-07-13 津国肇 Method for preserving of crude marine alga and preserved food thereof
CN1096953A (en) * 1993-07-02 1995-01-04 周勇 A kind of Chinese medicine for the treatment of osteoporosis

Also Published As

Publication number Publication date
CN1155430A (en) 1997-07-30

Similar Documents

Publication Publication Date Title
CN101130030B (en) Medicine composition for treating nephropathy and uses of the same
CN101940658B (en) Chinese medicinal composition for treating toothache and preparation method thereof
CN109170476A (en) Health food containing witloof
CN1049832C (en) Medicine for lithiasis and its preparing method
CN1055853C (en) Chinese drug for osteoporosis and the preparation thereof
CN1748727A (en) Granular powder for strengthening spleen and nourishing stomach and preparing method
CN102671178A (en) Chinese medicinal composition for treating nephrotic syndrome and uremia and preparation method and application thereof
CN102670892A (en) Medicament for treating infantile diarrhea
CN101954022B (en) Chinese medicinal composition for treating lung cancer
CN1086144C (en) Capsule for tonifying kidney
CN104147340B (en) Treat rheumatism, the Chinese medicine composition of rheumatoid arthritis
CN1105557A (en) Method for preparation of weight-loosing medicine and its products
CN101670009A (en) Traditional Chinese medicine composite for treating pig inappetence and preparation method thereof
CN112773875A (en) Liver-protecting pill and preparation method thereof
CN1079252C (en) Compound graceful jassamine preparation
CN101780188B (en) Capsule for treating prostatic diseases
CN104208233A (en) Lonicera, Forsythia and isatis root powder for aquatic products, and its preparation method
CN1559496A (en) Chinese medicine preparation of removing obstruction in the channels for treating atrophic arthritis
CN106266489A (en) One treats osteoporosis Chinese patent medicine
CN102274483A (en) Chinese medicinal powder for preventing and treating gastroenteritis in swine
CN102949606A (en) Chinese medicinal composition for treating female climacteric syndrome
CN1081044C (en) Prescription, preparation of medicine for treating cancer and its instructions of taking medicine
CN1068780C (en) "Anluohuaxianwan" pill and producing process thereof
CN104888050A (en) Drug for treating constipation
CN108704005A (en) A kind of livestock and poultry pharmaceutical composition and its preparation method and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee